Grethe Nørskov Rasmussen

Corporate Officer/Principal presso FLUOGUIDE A/S

Patrimonio netto: 2 M $ in data 31/03/2024

62 anni

100 relazioni

Health Technology

Commercial Services

Consumer Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Lars Fruergaard Jorgensen	M	58	NOVO NORDISK A/S	33 anni
Albert Cha	M	51	ASCENDIS PHARMA A/S	10 anni
Peter Morch Eriksen	M	64	FLUOGUIDE A/S	5 anni
Andreas Kjaer	M	61	FLUOGUIDE A/S	6 anni
Shomit Ghose	M	63	FLUOGUIDE A/S	5 anni
Scott Smith	M	50	ASCENDIS PHARMA A/S	8 anni
Lars Holtug	M	66	ASCENDIS PHARMA A/S	6 anni
Peter Rasmussen	M	55	ASCENDIS PHARMA A/S	10 anni
Lisa Bright	F	56	ASCENDIS PHARMA A/S	7 anni
Karsten Munk Knudsen	M	53	NOVO NORDISK A/S	25 anni
Henrik Ehlers Wulff	M	54	NOVO NORDISK A/S	25 anni
Morten Albrechtsen	M	60	FLUOGUIDE A/S	6 anni
Micaela Sjökvist	F	54	FLUOGUIDE A/S	5 anni
Mats Johan Peter Thorén	M	53	FLUOGUIDE A/S	3 anni
Camilla Sylvest	F	52	NOVO NORDISK A/S	28 anni
Maziar Mike Doustdar	M	54	NOVO NORDISK A/S	32 anni
Flemming Steen Jensen	M	63	ASCENDIS PHARMA A/S	9 anni
Ole Larsen	M	59	FLUOGUIDE A/S	1 anni
Michael Engsig	M	-	FLUOGUIDE A/S	1 anni
Dorthe Gronnegaard Mejer	F	49	FLUOGUIDE A/S	4 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Jakob Riis	M	58	NOVO NORDISK A/S	21 anni
Martin Olin	M	55	ASCENDIS PHARMA A/S NOVO NORDISK A/S	9 anni
Christian Hansen	M	58	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. NOVO NORDISK A/S Technical University of Denmark	11 anni
Thomas Soloway	M	55	ASCENDIS PHARMA A/S	5 anni
James Sulat	M	73	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	10 anni
Rafaèle Elisabeth Tordjman	M	54	ASCENDIS PHARMA A/S	10 anni
Birgitte Volck	M	61	ASCENDIS PHARMA A/S	7 anni
Peder Holk Nielsen	M	67	NOVO NORDISK A/S Technical University of Denmark	10 anni
Thomas Videbaek	M	63	Technical University of Denmark	5 anni
Torben Nissen	M	53	ASCENDIS PHARMA A/S Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	3 anni
Carsten Hellmann	M	60	NOVO NORDISK A/S	-
Birgitte Skou Holck-Andersen	M	67	Technical University of Denmark	4 anni
Søren Thuesen Pedersen	M	59	Technical University of Denmark NOVO NORDISK A/S	29 anni
Per Falholt	M	65	Technical University of Denmark NOVO NORDISK A/S	18 anni
Jan Mikkelsen	M	65	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA. NOVO NORDISK A/S	14 anni
Mette Dobel	F	57	Technical University of Denmark	5 anni
John M. Borkholder	M	55	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	8 anni
Egill Jónsson	M	67	Technical University of Denmark	1 anni
Arne Ferstad	M	74	FLUOGUIDE A/S	2 anni
Gudmund Knudsen	M	-	Technical University of Denmark	5 anni
Henrik Schimmell	M	62	Technical University of Denmark	5 anni
Jack Nielsen	M	60	NOVO NORDISK A/S Technical University of Denmark	12 anni
Harry H. Penner	M	78	NOVO NORDISK A/S	8 anni
Louis Lange	M	72	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	8 anni
Kurt Anker Nielsen	M	78	NOVO NORDISK A/S	13 anni
Jonathan Silverstein	M	57	ASCENDIS PHARMA A/S	-
Jesper Brandgaard	M	60	NOVO NORDISK A/S	20 anni
Kåre Schultz	M	62	NOVO NORDISK A/S	26 anni
Mads Krogsgaard Thomsen	M	63	NOVO NORDISK A/S	30 anni
James Healy	M	58	ASCENDIS PHARMA A/S	8 anni
Ernest Mario	M	85	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	12 anni
Elliot Goldstein	M	73	Maxygen, Inc. Maxygen, Inc. Miscellaneous Commercial ServicesCommercial Services Maxygen, Inc. is a biotechnology company. It is focused on the potential further development of its MAXY-G34 product, a next-generation pegylated, granulocyte colony stimulating factor, G-CSF, for the treatment of chemotherapy induced neutropenia and acute radiation syndrome. G-CSF is a natural protein that functions by stimulating the body's bone marrow to produce more white blood cells. The company was founded on May 7, 1996 and is headquartered in San Mateo, CA.	6 anni
Thomas Kähler	M	53	Technical University of Denmark	4 anni
Joan Schmidt	F	60	NOVO NORDISK A/S	20 anni
Carmen Valcarce	M	-	NOVO NORDISK A/S	-
Eva Berneke	F	55	Technical University of Denmark	4 anni
Thomas Lethenborg	M	55	Technical University of Denmark	5 anni
Tina Sejersgård Fanø	F	55	Technical University of Denmark	4 anni
Christopher Yallop	M	-	NOVO NORDISK A/S	6 anni
Lars Green	M	57	NOVO NORDISK A/S	27 anni
Jan Behrendt Ibsoe	M	-	Technical University of Denmark	1 anni
Gitte L. Pedersen	F	61	NOVO NORDISK A/S	10 anni
Charlotte Dyring	M	56	Technical University of Denmark	4 anni
Henrik Dalsgard	M	-	Technical University of Denmark	3 anni
Michael Troensegaard Andersen	M	63	Technical University of Denmark	-
Anders Heine Jensen	M	60	Technical University of Denmark	5 anni
Hong Jiang Zhang	M	63	Technical University of Denmark	5 anni
Anna Héléne Barnekow	F	60	NOVO NORDISK A/S	2 anni
Liselotte Hyveled	F	58	NOVO NORDISK A/S	26 anni
Gustav Christen Mellentin	M	58	Technical University of Denmark	5 anni
Annette Stube	F	57	NOVO NORDISK A/S	11 anni
Christoffer Leif Feilberg	M	-	Technical University of Denmark	5 anni
Kaspar von Meyenburg	M	-	Technical University of Denmark	9 anni
Robert Frederick Caspari	M	78	NOVO NORDISK A/S	4 anni
Bo Pedersen	M	-	Technical University of Denmark	3 anni
Lars Boettern	M	-	Technical University of Denmark	4 anni
Valeta A. Gregg	M	72	NOVO NORDISK A/S	5 anni
Peter David Suzdak	M	65	NOVO NORDISK A/S	7 anni
Jan Ulf Sigvar J. Johansson	M	79	NOVO NORDISK A/S	7 anni
Anders Hove	M	58	Technical University of Denmark	6 anni
Claus Tycho Bræstrup	M	79	NOVO NORDISK A/S	10 anni
Lars Kongsbak	M	63	Technical University of Denmark	3 anni
Steve Wang	M	-	Technical University of Denmark	3 anni
C. Ahlefeldt-Laurvig	M	-	Technical University of Denmark	1 anni
Carsten Bjerg	M	64	Technical University of Denmark	4 anni
Christian Gröndahl	M	60	NOVO NORDISK A/S	14 anni
Jens Maaløe	M	69	Technical University of Denmark	3 anni
Casper Breum	M	57	Technical University of Denmark	5 anni
Steen Riisgaard	M	73	NOVO NORDISK A/S	21 anni
Christian V. Olgaard	M	-	Technical University of Denmark	10 anni
Leif Kongerslev	M	71	NOVO NORDISK A/S	-
Stig Strøbæk	M	60	NOVO NORDISK A/S	30 anni
Peter Ruhdal Jensen	M	-	Technical University of Denmark	3 anni
Bo Stig Hansen	M	-	Technical University of Denmark	13 anni
Gorm Heron	M	-	Technical University of Denmark	1 anni
René Svendsen-Tune	M	69	Technical University of Denmark	4 anni
Allan Rasmussen	M	57	Technical University of Denmark	4 anni
Henrik Jeberg	M	-	Technical University of Denmark	6 anni
Michael Berggreen Petersen	M	-	Technical University of Denmark	3 anni
Jacob Michelsen	M	-	Technical University of Denmark	5 anni

Statistiche

Paese	Relazioni	% del totale
Danimarca	95	95.00%
Stati Uniti	8	8.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni